Don't want to be a downer, but what are the chances of this leading to a commercially viable product before COVID ceases to be relevant?
Or is the resulting product likely to be applicable to other pathogens (all?) besides COVID?
Biotome Partnership, page-140
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.010(4.35%) |
Mkt cap ! $408.3M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.0¢ | $1.892M | 8.387M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 473422 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 62936 | 4 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
22.3¢ |
Change
-0.010 ( 5.12 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.5¢ | 22.0¢ | 6208956 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| BRN (ASX) Chart |